
zzso pain in patients with advanced cancer poses a serious clinical zzso The zzso zzso zzso zzso spray zzso zzso zzso zzso zzso is a novel zzso zzso currently undergoing investigation as an zzso therapy for this treatment zzso 

This follow-up study investigated the long-term safety and zzso of zzso spray and zzso spray in zzso pain in patients with advanced zzso 

In total, 43 patients with zzso pain experiencing inadequate analgesia despite chronic zzso zzso who had participated in a previous zzso zzso spray, zzso spray, or zzso two-week parent zzso controlled trial, entered this zzso zzso follow-up zzso Patients zzso zzso spray zzso or zzso spray zzso to symptom relief or maximum dose and were regularly reviewed for safety, zzso and evidence of clinical zzso 

The efficacy end point of change from baseline in mean zzso zzso zzso Form scores for zzso zzso and zzso zzso zzso showed a decrease zzso zzso at each visit in the zzso spray zzso Similarly, the European Organization for Research and Treatment of Cancer Quality of Life zzso scores showed a decrease zzso zzso from baseline in the zzso of insomnia, pain, and zzso No new safety concerns associated with the extended use of zzso spray arose from this zzso 

This study showed that the long-term use of zzso spray was generally well zzso with no evidence of a loss of effect for the relief of zzso pain with long-term zzso Furthermore, patients who kept using the study medication did not seek to increase their dose of this or other zzso medication over time, suggesting that the zzso use of cannabinoids in zzso pain could provide useful zzso 

